Track the 유바이오로직스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 유바이오로직스 has published 74 public disclosures. Market capitalisation: €290.8bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 바이오노트. Every trade is openly available.
74
Insider Decl.
n/a
Thresholds
n/a
64 ops.
Buy Volume
n/a
1 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 214 of 29,057 companies
88.4
score / 100
Value
90
Quality
87
FCF yld11%
Earn yld14%
EV/EBITDA4.6x
ROE·
Gross mgn58%
Net mgn28%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
유바이오로직스 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo de soluciones biológicas innovadoras.